Skip to main content

GATC Biotech Installs Second HiSeq 2000 for Large-Scale Projects


This story was originally published July 8

German sequencing service provider GATC Biotech said last week that it will install a second Illumina HiSeq 2000 instrument, which will go into production later this month.

The company purchased its first HiSeq 2000 earlier this year (IS 1/26/2010). Both instruments will be used to sequence pediatric brain tumors for a project that is part of the International Cancer Genome Consortium (IS 5/25/2010), as well as for large population studies and screens for mutations causing rare diseases.

Besides the two HiSeq instruments, GATC is equipped with three Illumina GAs, two 454 GS FLX, and nine ABI 3730xl sequencers. The new HiSeq increases the firm's sequencing capacity to almost 20 terabases per year, the company said.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.